Swipe om te navigeren naar een ander artikel
This prospective study was performed to evaluate the effect of chemotherapy-related neurotoxicity on quality of life (QOL) of patients with lymphoma.
Thirty-two patients with diffuse large B-cell or follicular lymphoma without prior evidence of neuropathy were enrolled. Patients underwent the evaluations based on neuropathy symptom and disability score, nerve conduction studies, and SF-36 questionnaire for QOL assessment. They received six cycles of chemotherapy every three weeks, and all evaluations were repeated during and after the completion of 6th cycle.
Sensory neuropathy-associated symptoms were observed in 27 patients (84.4%), and polyneuropathy was confirmed by nerve conduction study in 14 patients (43.8%). These patients with polyneuropathy showed worse QOL in domains mainly associated with physical health status including “physical function” compared to patients without polyneuropathy. There was a significant association of neuropathy symptom and disability scores with “bodily pain” and “vitality” of QOL domains. The serial evaluations of patients with neuropathy showed a worsening of QOL and neuropathy symptom scores during chemotherapy, then improvement of these values after chemotherapy. Thus, the final nerve conduction study confirmed the decrease in polyneuropathy compared to the 2nd evaluation (P = 0.032).
Chemotherapy-related polyneuropathy may deteriorate QOL of patients with lymphoma, mainly physical health-associated QOL.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
van Oers, M. H., Klasa, R., Marcus, R. E., Wolf, M., Kimby, E., Gascoyne, R. D., et al. (2006). Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood, 108, 3295–3301. CrossRefPubMed
Morita, S., Kobayashi, K., Eguchi, K., Matsumoto, T., Shibuya, M., Yamaji, Y., et al. (2003). Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model. Japanese Journal of Clinical Oncology, 33, 470–476. CrossRefPubMed
Bruner, D. W., Barsevick, A., Tian, C., Randall, M., Mannel, R., Cohn, D. E., et al. (2007). Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. Quality of Life Research, 16, 89–100. CrossRefPubMed
Klasa, R. J., Meyer, R. M., Shustik, C., Sawka, C. A., Smith, A., Guevin, R., et al. (2002). Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin’s lymphoma previously treated with an alkylating agent or alkylator-containing regimen. Journal of Clinical Oncology, 20, 4649–4654. CrossRefPubMed
Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36 physical and mental health summary scales: A user’s manual. Boston, MA: The Health Institute.
- Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma
Hak Jae Roh
Byung Soo Kim
S. Charles Cho
Yuen T. So
Sung Yong Oh
Seok Jin Kim
- Springer Netherlands